Although our data suggest that direct tumor cytotoxicity is not a likely mechanism of E6- and KRASG12V-specific CD4+ T cells, other antitumor mechanisms of CD4+ T cells have been described, and adoptive transfer of tumor-specific CD4+ T cells in patients with cancer has demonstrated antitumor activity (7, 40, 41). This evidence concerns the gene CD4 and cancer.